Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMuscle cramps and stomach cramps are both reported by people taking semaglutide, but the picture is more nuanced than a simple yes. Semaglutide is strongly linked to gastrointestinal discomfort, including abdominal cramping, yet it does not appear in the licensed side-effect data as a common cause of skeletal muscle cramps in the limbs. Understanding which type of cramp you are experiencing (and why) makes it much easier to know what to do next. These medicines are prescription-only, and any new or worsening physical symptoms are always worth raising with the prescriber who oversees your treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When people ask whether semaglutide causes cramps, they often have one of two very different experiences in mind. The first is stomach cramping — a tight, griping pain in the abdomen that comes and goes, sometimes with bloating or an urgent need to visit the bathroom. The second is the kind of cramp more associated with exercise or dehydration: a sudden, sharp contraction in the calf, thigh or foot. These feel similar enough to describe with the same word, but their causes and implications are quite different, and mixing them up leads to a lot of unnecessary worry in one direction and occasionally not enough in the other.
Semaglutide works by activating GLP-1 receptors, which slow the rate at which the stomach empties and alter how the gut moves food along. That mechanical change is exactly why abdominal cramps happen on treatment. The gut is doing something different, and for many people it protests, at least initially. The NHS patient information on semaglutide lists nausea, vomiting, diarrhoea, constipation and stomach pain among the common side effects, stomach cramping fits naturally into that cluster. Leg cramps or muscle cramps elsewhere in the body are a separate matter, and the evidence for semaglutide as a direct cause there is far thinner.
If you are trying to work out which applies to you, our guide to semaglutide cramps walks through both types in detail, but a useful rule of thumb is location: does the discomfort feel like it is inside your abdomen, or is it a distinct muscle contraction in your limb? Both deserve attention, but the path forward is slightly different for each.
Gastrointestinal side effects, including stomach cramps, are the most consistently reported experience among people using semaglutide for weight management. In the STEP 1 clinical trial, the majority of GI events occurred early in treatment and during dose increases, with most resolving as the body adjusted. The slow titration schedule (moving up through doses over several months) exists partly for this reason. It gives your gut time to adapt rather than being confronted with a full maintenance dose from day one.
For most people, stomach cramping is worst in the first week or two after starting a new dose. Eating smaller portions, avoiding high-fat or very rich foods, and staying well hydrated all help. Some people find that cramping is worse if they eat too quickly or too much in one sitting, which makes sense given that gastric emptying is already slowed. There is also a timing element worth keeping in mind: if your injection day happens to fall on a day when your routine is disrupted (a bank holiday, the end of the month when life is busy, a long journey) having a plan for managing early side effects in advance can make a real difference.
If you are finding stomach cramps particularly difficult, your prescriber can discuss whether slowing your titration pace or adjusting how you take the medicine might help. Questions like this, including how cramps on Wegovy tend to develop and what most people find helps, are exactly what our guide to semaglutide and cramps goes into in more detail.
Some people taking semaglutide do report leg cramps, and it would be misleading to dismiss the experience. The most plausible explanation in most cases is indirect: significant nausea, vomiting or diarrhoea can lead to dehydration and electrolyte shifts, and low levels of magnesium, potassium or sodium are well-established triggers for muscle cramps. The medicine itself may not be cramping the muscle directly; the gut symptoms it causes may be affecting the body's fluid and mineral balance enough to tip things over.
This is why hydration is emphasised so consistently during GLP-1 treatment. If vomiting or diarrhoea has been a feature of your experience, replacing fluids and electrolytes (through food, drinks or electrolyte supplements, depending on what your prescriber advises) is a sensible first step before assuming the cramps are an unavoidable feature of the medicine. A detailed look at whether Wegovy specifically is associated with leg cramps is available in our dedicated page on Wegovy and leg cramps.
There are also situations where cramps signal something that needs ruling out. Severe stomach pain radiating to the back, particularly if persistent, is a symptom that warrants prompt medical review, the MHRA highlighted acute pancreatitis as an infrequent but serious risk with GLP-1 medicines in a Drug Safety Update published in January 2026. This is rare, but it is the reason that dismissing all abdominal pain as a normal side effect without assessment is not the right approach.
Most cramps on semaglutide are benign, temporary and manageable. But two categories of cramp deserve a call or message to your prescriber rather than watchful waiting. The first is severe abdominal pain that does not ease, particularly if it spreads to the back or comes with vomiting that will not settle. The second is any cramp that appears suddenly, is significantly worse than anything you experienced before starting treatment, or is accompanied by other new symptoms such as swelling, weakness or changes in urination.
You can report any suspected side effect, including cramps, directly through the MHRA Yellow Card scheme, doing so helps build the safety evidence base for everyone using these medicines. If you are unsure whether what you are experiencing falls into the normal-adjustment category or something that needs attention, asking is always the right call. Our prescribers and aftercare team are available seven days a week, and there is no such thing as a question that is too minor to raise.
If you are still deciding whether semaglutide is the right option for you, our overview of Wegovy in the UK covers how the medicine works, who it is licensed for and what the treatment process involves. For a broader look at the weight-loss options available through a clinically supervised route, our treatments overview is a good starting point. And for anyone thinking about the cost side of things, our Wegovy price comparison guide explains what different providers charge and what those prices typically do and do not include, including how med spas offering semaglutide compare on price and clinical oversight.
If the information here has been reassuring and you would like to explore treatment, check your eligibility with a free consultation, a real prescriber, not an automated system, reviews every application the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.